Safety profile of a divided dose of propranolol for heart rate in children with infantile haemangioma during 16 weeks of treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|172|2|444-449

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.2, 2015-02, pp. : 444-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low‐dose propranolol regimen for infantile haemangioma

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 4, 2015-04 ,pp. : 419-424

John Wiley & Sons Inc

Access to resources Recommend Favorite

Propranolol Safety Profile in Children

By  

Current Drug Safety, Vol. 6, Iss. 4, 2011-09 ,pp. : 259-266

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e51-e52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with propranolol for infantile hemangiomas: single‐center experience

By  

JOURNAL OF COSMETIC DERMATOLOGY, Vol. 15, Iss. 3, 2016-09 ,pp. : 296-302

John Wiley & Sons Inc

Access to resources Recommend Favorite

Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 242-246

John Wiley & Sons Inc

Access to resources Recommend Favorite